Minimal important difference of the 6-minute walk test after allogenic hematopoietic stem cell transplantation.
Disabil Rehabil
; : 1-8, 2023 Aug 13.
Article
en En
| MEDLINE
| ID: mdl-37574839
Advancements in allogeneic hematopoietic stem cell transplantation have improved the survival rates of individuals with malignant hematological disorders, and efforts should now be focused on enhancing their physical function and quality of life.There is a problem that the physical performance of the patients is reduced by the side effects of treatment.More careful follow-up after discharge is necessary for allo-HSCT patients who show a reduction of 37.5 m or more in the acute illness phase.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Aspecto:
Patient_preference
Idioma:
En
Revista:
Disabil Rehabil
Asunto de la revista:
REABILITACAO
Año:
2023
Tipo del documento:
Article
País de afiliación:
Japón